Teva Pharmaceutical Industries (NYSE:TEVA) Receives Hold Rating from Maxim Group

Marco Green
March 19, 2018

(NASDAQ:AMZN). Duff & Phelps Inv Mgmt has 0.06% invested in, Inc. The stock price dropped with downswing change of -5.57% when it was compared to 20-day moving average., Inc. (NASDAQ:AMZN) has risen 37.41% since March 19, 2017 and is uptrending. It has outperformed by 10.05% the S&P500.

Trust Company decreased its stake in Teva Pharmaceutical Inds Ltd (TEVA) by 59.36% based on its latest 2017Q3 regulatory filing with the SEC. Cam Group Holding A bought 76,038 shares as the company's stock declined 15.11% while stock markets rallied. The hedge fund held 462,200 shares of the major banks company at the end of 2017Q3, valued at $33.62 million, down from 530,300 at the end of the previous reported quarter.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) closed its last session at $18.37. The latest exchange of 0.17 Million shares is below its average trading activity of 133.65 Million shares. Guardian Investment Management now owns 17,700 shares of the company's stock worth $311,000 after acquiring an additional 3,750 shares during the last quarter. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since March 19, 2017 and is downtrending. It has underperformed by 58.40% the S&P500.

Opus Invest holds 1.04% or 62,900 shares in its portfolio. Its down 0.12, from 1 in 2017Q2. 91 funds opened positions while 196 raised stakes. Zwj Invest Counsel Inc has invested 1.78% in The Procter & Gamble Company (NYSE:PG).

Among new and sold out positions, 93 holders initiated new positions by a total of 51.18 million shares and 123 holders exited their positions by a total of 12.14 million shares. Rowland Invest Counsel Adv stated it has 8,174 shares or 0.3% of all its holdings. Proshare Advsr Lc owns 145,285 shares. The company's Market capitalization is 540.49M with the total Outstanding Shares of 137.88M. Gateway Invest Advisers Llc invested in 5.89M shares. American Century has 10,181 shares for 0% of their portfolio. According to their observations and findings, the stock could provide a high EPS of $0.75/share and a low EPS of $0.52/share. Vantage Investment Advisors Llc holds 79,273 shares or 2.65% of its portfolio. Baldwin Brothers Ma owns 313,414 shares or 1.28% of their United States portfolio. Wms Partners Ltd Liability Corp reported 195,461 shares. Villere St Denis J & Communications Ltd Liability holds 63,574 shares. Moreover, Nelson Van Denburg Campbell Wealth Management Grp Ltd has 0.25% invested in Bank of America Corporation (NYSE:BAC). They expect $0.59 earnings per share, up 43.90% or $0.18 from last year's $0.41 per share. The third largest holder is Wellington Management Group Llp, which now holds $875.72 million worth of this stock and that ownership represents almost 4.73% of its market capitalization.

Among 25 analysts covering Proctor & Gamble (NYSE:PG), 12 have Buy rating, 1 Sell and 12 Hold. Therefore 93% are positive. Tracking the stock price in relation to moving averages as well as highs and lows for the year might assist with evaluating future stock performance. TEVA stock price revealed pessimistic move of -10.19% comparing average price of last 200 days. Johnson & Johnson had 91 analyst reports since August 7, 2015 according to SRatingsIntel. The stock has "Buy" rating by Piper Jaffray on Monday, September 4. On Tuesday, October 6 the stock rating was maintained by Oppenheimer with "Outperform". As per Thursday, April 28, the company rating was maintained by JP Morgan. (NASDAQ:FB) earned "Buy" rating by Canaccord Genuity on Thursday, November 5. The company was maintained on Tuesday, August 15 by Jefferies. The firm has "Buy" rating by RBC Capital Markets given on Friday, October 13. The rating was maintained by Citigroup with "Neutral" on Monday, November 13. Teva Pharmaceutical Industries has an average rating of "Hold" and an average price target of $20.81. Raymond James Fin Svcs Advsrs Inc accumulated 105,449 shares. Migdal Insurance & Financial Holdings Ltd. now owns 6,035,644 shares of the company's stock valued at $106,271,000 after buying an additional 259,891 shares in the last quarter. Cowen & Co maintained the shares of TEVA in report on Wednesday, October 4 with "Hold" rating. TEVA's profit will be $650.80 million for 7.18 P/E if the $0.64 EPS becomes a reality. (NASDAQ:FB). Grand Jean Mgmt Inc reported 111,192 shares. Ten investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and eight have assigned a buy rating to the company's stock. Therefore 26% are positive. Stelac Advisory Services LLC acquired a new position in Teva Pharmaceutical Industries during the 3rd quarter worth approximately $326,000.

Analysts expected the average price target of $19.38 that is probable to reach in coming one year period. Teva Pharma had 147 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has "Hold" rating by Guggenheim on Tuesday, March 13. Stifel Nicolaus has "Buy" rating and $120 target. (NASDAQ:FB) rating on Thursday, November 2. Leerink Swann maintained the shares of TEVA in report on Friday, January 26 with "Sell" rating. BTIG Research downgraded shares of Teva Pharmaceutical Industries from a "buy" rating to a "neutral" rating and set a $24.00 price objective for the a report on Thursday, January 18th. Teva Pharmaceutical Industries's quarterly revenue was down 15.9% on a year-over-year basis. research analysts forecast that Teva Pharmaceutical Industries will post 2.3 earnings per share for the current year.

Other reports by Click Lancashire

Discuss This Article